Reagents and diagnostic supplies for microbiology testing
Ended Awarded Last action
- Contract number
- N6890817F0094
- Awardee
-
Fisher Scientific Company L.L.C. UEI F5TEGZ32EJ38 Part of Thermo Electron Corporation
- Awarding agency
-
Bureau of Medicine and Surgery
Department of the Navy, Department of Defense
- Obligated
- $209,875
Award facts
- Contract value 79% obligated
-
- $209,875.07 Current, with exercised options
- $266,991.04 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Houston, TX 77038, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $55,199 | |
| Exercise an Option | $0 | |
| Exercise an Option | $53,346 | |
| Exercise an Option | $51,548 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $49,782 |
About this award
This federal contract was awarded by the Defense Health Agency to Fisher Scientific Company L.L.C. Fisher Healthcare Division, doing business as Fisher Healthcare, to provide reagents and diagnostic supplies for microbiology testing. The contract is a Firm Fixed Price Delivery Order under the GSA Schedule 65-VII for in-vitro diagnostics, reagents, and test kits. The potential value of the contract is $266,991.04, with a completion date of September 30, 2022. The contract has no set-aside designation. Fisher Healthcare is the prime contractor, and its parent company is Thermo Electron Corporation Financial Services Division, which has provided various scientific equipment and services to federal agencies in the past. This contract supports the procurement of critical diagnostic materials for the Defense Health Agency.
Quick answers
Who was awarded contract N6890817F0094?
N6890817F0094 was awarded to Fisher Scientific Company L.L.C. by Bureau of Medicine and Surgery (Department of the Navy) on October 1, 2017.
How much is contract N6890817F0094 worth?
The government has obligated $209,875 on N6890817F0094. Its potential value, with all options, is $266,991.
Which agency awarded contract N6890817F0094?
Bureau of Medicine and Surgery (Department of the Navy) awarded N6890817F0094, with funding from Defense Health Agency (Department of Defense).
Is contract N6890817F0094 an order under another contract?
Yes. N6890817F0094 is a delivery order under V797P5992X, a federal supply schedule, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract N6890817F0094 competed?
The extent of competition for N6890817F0094 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award